Cargando…
HSDL2 Acts as a Promoter in Pancreatic Cancer by Regulating Cell Proliferation and Lipid Metabolism
BACKGROUND: Pancreatic cancer (PC) is a leading cause of cancer mortality worldwide. Hydroxysteroid dehydrogenase like protein 2 (HSDL2) is overexpressed in a variety of malignant tumors and is might be closely related to the development of cancer. It also regulates different metabolism and signalin...
Autores principales: | Han, Anna, Xu, Ran, Liu, Ying, Yin, Xianglin, Lin, Zhenhua, Yang, Wanshan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7814248/ https://www.ncbi.nlm.nih.gov/pubmed/33488098 http://dx.doi.org/10.2147/OTT.S287722 |
Ejemplares similares
-
Lipid metabolism regulator human hydroxysteroid dehydrogenase‐like 2 (HSDL2) modulates cervical cancer cell proliferation and metastasis
por: Yang, Yang, et al.
Publicado: (2021) -
Ectopic expression of HSDL2 is related to cell proliferation and prognosis in breast cancer
por: Dong, Bing, et al.
Publicado: (2019) -
Down-regulated HSDL2 expression suppresses cell proliferation and promotes apoptosis in papillary thyroid carcinoma
por: Zeng, Jing, et al.
Publicado: (2019) -
HSDL2 Promotes Bladder Cancer Growth In Vitro and In Vivo
por: Jia, Ling-Hua, et al.
Publicado: (2019) -
Cucurbitacin E inhibits cellular proliferation and induces apoptosis in melanoma by suppressing HSDL2 expression
por: Liu, Wen-Bei, et al.
Publicado: (2022)